Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam plus alfentanil versus propofol plus alfentanil for deep sedation during fiberoptic bronchoscopy in elderly patients
ChiCTR2400083383Phase 4Not yet recruiting
- Sponsor
- Lishui People's Hospital
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam, alfentanil and propofol (2 arms), sponsored by Lishui People's Hospital. Primary endpoint: Hypoxemia. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
remimazolamalfentanilpropofol
Beyond the preview
Go deeper on ChiCTR2400083383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083383.